Anebulo Pharmaceuticals Inc (ANEB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 06/30
09-2021 | 06-2021 | 03-2021 | 12-2020 | 09-2020 | |
Operating Expenses | 1,555 | 2,485 | 552 | 325 | 252 |
Operating Income | -1,555 | -2,485 | -552 | -325 | -252 |
Interest Expense | 0 | 12 | 0 | 0 | 0 |
Other Income | 2 | -26,615 | -4 | -4 | -4 |
Pre-tax Income | -1,553 | -29,112 | -556 | -329 | -256 |
Net Income Continuous | -1,553 | -29,112 | -556 | -329 | -256 |
Net Income | $-1,553 | $-29,112 | $-556 | $-329 | $-256 |
EPS Basic Total Ops | -0.07 | -1.59 | -0.68 | -0.03 | -0.02 |
EPS Basic Continuous Ops | -0.07 | -1.59 | -0.04 | -0.03 | -0.02 |
EPS Diluted Total Ops | -0.07 | -1.59 | -0.68 | -0.03 | -0.02 |
EPS Diluted Continuous Ops | -0.07 | -1.59 | -0.04 | -0.03 | -0.02 |
EBITDA(a) | $-1,555 | $-2,485 | $-552 | $-325 | $-252 |